DGAP-News: IBS AG excellence, collaboration, manufacturing: IBS AG achieves a clear increase in all

DGAP-News: IBS AG excellence, collaboration, manufacturing: IBS AG achieves a clear increase in all key financial figures as at 30.09.2010, once again reaching the level of 2008

ID: 32496

(firmenpresse) - IBS AG excellence, collaboration, manufacturing / Key word(s): Quarter Results/Preliminary Results

05.11.2010 07:00
---------------------------------------------------------------------------

* Overall turnover rose by more than 11 per cent during the first nine
months of 2010, to a volume of 14.8M EUR
* EBIT more than doubled, reaching a volume of 1.46M EUR and an EBIT margin
of 10 per cent
* The volume of orders on hand of 13M EUR is the highest since 2003
* Liquid funds rose by more than 16 per cent to 6.5M EUR

Hoehr-Grenzhausen, 5th November 2010: IBS AG Corporate Group turnover
amounted to 14.8M EUR during the first nine months of the current financial
year 2010. Compared to 13.3M EUR generated during the same period of the
previous year, this corresponded to an increase of 11 per cent. Turnover
from software licence sales and maintenance agreements also increased by 7
per cent to 9.04M EUR during the same period (previous year: 8.38M EUR).
Turnover from hardware sales rose slightly to 807K EUR (previous year: 231K
EUR), as did turnover from project-related services, which increased by 6
per cent to 4.95M EUR compared to 4.67M EUR during the same period of the
previous year.

The sluggish project development caused by cyclical bottlenecks in
personnel capacity and investment restrictions during the 2009 financial
year appeared to have been overcome in IBS AG's target industries. IBS
sensed a general upturn in demand during the current financial year, in
particular in growth regions, such as China.

This was confirmed by the volume of orders on hand from project and
maintenance orders for the next 12 months, which amounted to 13.1M EUR as
at 30th September 2010 and reached its highest level since that of the 2003
financial year. Compared to the same period of the previous year, the
volume of orders on hand rose by approximately 15 per cent (previous year:




11.44M EUR).

Earnings before interest, taxes, depreciation and amortization amounted to
2.02M EUR during the first nine months of the year (previous year: 1.05M
EUR). This corresponded to a 92 per cent increase compared to the same
period of the previous year and an EBITDA margin of approximately 14 per
cent (previous year: 8 per cent).

IBS AG Corporate Group earnings before interest and taxes (EBIT) almost
doubled during the period under review and amounted to 1.461K EUR, compared
to 588K EUR generated during the same period of the previous year. The EBIT
margin corresponded to approximately 10 per cent. The period surplus for
the Corporate Group, which amounted to 1.444K EUR (previous year: 537K
EUR), more than doubled. This corresponded to diluted and undiluted
earnings per share (EPS) of 0.22 EUR (previous year: 0.08 EUR). This value
is more than double that of the same period of the previous year.

Liquid funds amounted to 6.5M EUR as at 30th September 2010 (30th September
2009: 5.58M EUR), representing an increase of over 16 per cent.
Shareholder's equity further increased to 15.13M EUR (30th September 2009:
14.03M EUR). The IBS AG shareholder's equity ratio is thus 65 per cent.

The single company IBS AG achieved a 17 per cent increase in turnover to
approximately 11M EUR in the nine-month comparison (previous year: 9.41M
EUR) and a 33 per cent increase in EBIT of 1,329K EUR (previous year:
1,001K EUR). Still influenced by the economic cycle, IBS America, Inc.
suffered a slight drop in turnover to 3.15M EUR (previous year: 3.32M EUR).
There was, however, a positive development in earnings before interest and
taxes, which amounted to 57K EUR (previous year: -211K EUR). In the rest of
Europe (excluding Germany) the Company generated a 24 per cent increase in
turnover, which amounted to 1.591K EUR (previous year: 1.280K EUR).

The IBS AG Corporate Group generated turnover of 5.08M EUR during the third
quarter (Q3 2009: 4.10M EUR), which corresponded to an increase of 24 per
cent. Earnings before interest, taxes, depreciation and amortization
amounted to 731K EUR during the same period (Q3 2009: 233K EUR). The EBITDA
margin corresponded to approximately 14 per cent. Earnings before interest
and taxes (EBIT) amounted to 502K EUR during the third quarter of 2010 (Q3
2009: 51K EUR), which represented an almost tenfold increase. The EBIT
margin corresponded to 10 per cent.

The clear increase in demand and the high volume of orders on hand of 13.1M
EUR as at 30th September 2010 (previous year: 11.44M EUR) shall ensure the
further growth of the software company.

The Company's quarterly report for the third quarter of 2010 will be
published on 11th November 2010 and will be available for download from
www.ibs-ag.de from this time.

Contact:
Nina Yvonne Slegers
IBS AG
Rathausstrasse 56
56203 Hoehr-Grenzhausen
Tel. 49 2624 9180424
Fax: 49 2624 9180966




05.11.2010 07:00 Dissemination of a Corporate News, transmitted by DGAP -
a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------

Language: English
Company: IBS AG excellence, collaboration, manufacturing
Rathausstrasse 56
56203 Hoehr-Grenzhausen
Deutschland
Phone: 02624/ 9180-424
Fax: 02624/ 9180-966
E-mail: investorrelations(at)ibs-ag.de
Internet: www.ibs-ag.de
ISIN: DE0006228406
WKN: 622840
Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
in Hamburg, München, Düsseldorf, Berlin, Stuttgart

End of Announcement DGAP News-Service

---------------------------------------------------------------------------

Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  DGAP-News: EVN AG: Announcement pursuant to§93 (1) Austrian Stock Exchange Act DGAP-News: New clinical study started with the nicotine vaccine NIC002
Bereitgestellt von Benutzer: EquityStory
Datum: 05.11.2010 - 07:00 Uhr
Sprache: Deutsch
News-ID 32496
Anzahl Zeichen: 0

contact information:

Kategorie:

Business News



Diese Pressemitteilung wurde bisher 169 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"DGAP-News: IBS AG excellence, collaboration, manufacturing: IBS AG achieves a clear increase in all key financial figures as at 30.09.2010, once again reaching the level of 2008"
steht unter der journalistisch-redaktionellen Verantwortung von

IBS AG excellence, collaboration, manufacturing (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von IBS AG excellence, collaboration, manufacturing



 

Werbung



Sponsoren

foodir.org The food directory für Deutschland
News zu Snacks finden Sie auf Snackeo.
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z